Hippocampal Atrophy in Pediatric Transplant Recipients with Human Herpesvirus 6B

Misa Miyake1, Yoshiki Kawamura1, Naoko Ishihara1

  • 1Department of Pediatrics, Fujita Health University School of Medicine, Toyoake 470-1192, Japan.

Microorganisms
|April 30, 2021
PubMed

Insights

Human herpesvirus 6B (HHV-6B) infection in pediatric hematopoietic stem cell transplant (HSCT) recipients is linked to reduced hippocampal volume. This suggests potential neurological complications and the need for vigilant monitoring post-transplant.

Area of Science:

  • Neuroscience
  • Virology
  • Pediatric Hematology/Oncology

Background:

  • Pediatric hematopoietic stem cell transplantation (HSCT) is a critical treatment for various diseases.
  • Human herpesvirus 6B (HHV-6B) is a common opportunistic infection post-HSCT.
  • The impact of HHV-6B on the developing brain, particularly the hippocampus, remains incompletely understood.

Purpose of the Study:

  • To investigate the association between HHV-6B infection and hippocampal volume changes in pediatric HSCT recipients.
  • To determine if HHV-6B infection leads to hippocampal atrophy.
  • To assess the correlation between HHV-6B infection, hippocampal volume, and neurological outcomes.

Main Methods:

  • Retrospective analysis of pediatric HSCT recipients who underwent brain MRI before and after transplantation.
  • Volumetric analysis of hippocampal regions using MRI data.
  • Monitoring for HHV-6B infection and assessment of neurological symptoms, including encephalopathy.

Main Results:

  • A significant reduction in hippocampal volume was observed in pediatric HSCT recipients with HHV-6B infection compared to those without (Right hippocampus: p=0.007; Left hippocampus: p=0.003).
  • Four out of eight patients with HHV-6B infection showed a marked reduction in hippocampal volume (ratio < 0.90).
  • Encephalopathy was more prevalent in patients with HHV-6B infection.

Conclusions:

  • HHV-6B infection is associated with hippocampal volume reduction in pediatric HSCT recipients.
  • These findings highlight a potential neurotoxic effect of HHV-6B on the hippocampus.
  • Neurological surveillance is recommended for pediatric HSCT recipients diagnosed with HHV-6B infection.

Related Concept Videos

Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...